Sarah E. Slone, Ph.D.

Sarah concentrates primarily on protecting branded pharmaceutical and life science therapies in district courts and before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (PTAB). Her counseling practice centers on advising clients on patent drafting strategies, portfolio management, publishing risks, and invalidity and freedom-to-operate (FTO) opinions. Sarah is part of the firm’s tech licensing practice and is a member of the Licensing Executives Society (LES), USA and Canada. In her pro bono work, Sarah represents clients seeking asylum in immigration court and criminal defendants in the D.C. Superior Court. 

During law school, Sarah was on the student executive board for Tech Edge, a program at Santa Clara University designed to engage tech-savvy attorneys and promote mentoring networks in Silicon Valley. She was part of a team that placed second at the 2022 USPTO National Patent Drafting Competition. 

In both her undergraduate and graduate studies, Sarah researched the neurobiology of aging. She investigated the role of IL-1β in driving inflammation in the aged brain and the ameliorative effects of insulin and calcium channel antagonists on cognition and neurodegeneration. Sarah also studied neuro-immune interactions, focusing her research on complement component C1q’s contribution to neurogenesis decline and brain aging. 

While a graduate student, Sarah interned as a Research Translation Group Fellow with the University of California, Irvine (UCI) Beall Applied Innovation Center. She translated technical biomedical and engineering discoveries into layperson invention summaries and conducted prior art searches and patent landscape analyses.